Oral drug blocks SARS-CoV-2 transmission
sciencedaily.com
Oral drug blocks SARS-CoV-2 transmission
1–3 of 3 posts
Re: Oral drug blocks SARS-CoV-2 transmission
#2What’s the catch?
Re: Oral drug blocks SARS-CoV-2 transmission
#3What’s the catch?
Concerns about mutagenicity and acute toxicity. This is a derivative of Emory's N-hydroxycytidine, a nucleotide analog. Stuff's no good if it causes cancer 10 years down the line or bone marrow suppression right now.